The chemical class termed Hepatic Lipase Activators represents a specialized group of compounds capable of modulating cellular processes through the activation of hepatic lipase, an enzyme crucial for lipid metabolism and homeostasis. Hepatic lipase, predominantly expressed in the liver, plays a vital role in catalyzing the hydrolysis of triglycerides and phospholipids, contributing to the regulation of lipoprotein metabolism. The activation of hepatic lipase by these compounds involves specific molecular interactions, wherein activators engage with the enzyme, inducing conformational changes that enhance its catalytic efficiency in lipid hydrolysis. Advanced structural techniques, including X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, can be employed to elucidate the intricate details of the binding sites and conformational changes induced by Hepatic Lipase Activators.
The methods employed by Hepatic Lipase Activators are intricately tied to their structural features. These activators typically harbor specific chemical motifs that enable selective binding to hepatic lipase, promoting a targeted and efficient response. The specificity of this interaction is essential for the precise modulation of hepatic lipase activity in lipid metabolism. Structural studies, such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, can be employed to unravel the details of the binding sites and conformational alterations induced by Hepatic Lipase Activators. Understanding these molecular intricacies not only enhances our knowledge of hepatic lipase activation but also contributes to a broader understanding of lipid metabolism and its regulatory mechanisms within hepatocytes. In summary, the elucidation of these molecular methods provides valuable insights into the intricate mechanisms through which Hepatic Lipase Activators can influence cellular processes related to hepatic lipid homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
EPA is an omega-3 fatty acid that can modulate lipid metabolism. It might indirectly affect hepatic lipase function by altering the availability of its lipid substrates. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
DHA is another omega-3 fatty acid that can influence lipid metabolism. Its role in this pathway suggests potential indirect influence on hepatic lipase activity. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate is a drug that regulates lipid metabolism and could potentially influence hepatic lipase activity indirectly. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Rosuvastatin, a statin used to treat high cholesterol and related conditions, influences lipid metabolism and could indirectly affect hepatic lipase activity. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate is a fibrate drug used to reduce triglyceride levels. It affects lipid metabolism and could potentially have an indirect effect on hepatic lipase function. | ||||||